Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2010
05/25/2010US7723298 Cytokine receptor
05/25/2010US7723116 Flow cytometry involving the use of a pulsed laser to sort sperm cells; even split radiation beams are directed to multiple nozzles; differentiated sperm cells are separated at higher speeds and even into subpopulations having higher purity
05/25/2010US7723112 Tumor stem cell profile for diagnosis, characterization, prognosis and treatment of cell proliferative disodrers; tissue targeted therapy
05/25/2010US7723111 Anticancer agents; autoimmune disease
05/25/2010US7723110 Plant cell signaling genes
05/25/2010US7723109 Expression of spider silk proteins
05/25/2010US7723108 Thawing frozen donor dermis and decellularizing; inspecting for defects and trimming; sterilizing in a vacuum with a soak of propylene glycol, ethanol, water and peracetic acid; rinsing; cutting; immersing in ethanol; and packaging; the dermis is flexible when removal from package; ready for implanting
05/25/2010US7723107 Pharmaceutical composition for inducing an immune response in a human or animal
05/25/2010US7723106 Bovine serum albumin as a serum substitute; insulin and transferrin; thrombopoietin; stem cell factor; stem cell growth factor-alpha, Flt-3 ligand; interleukin-3, IL-6, IL-11; granulocyte colony-stimulating factor (G-CSF); granulocyte-macrophage and colony-stimulating factor
05/25/2010US7723105 Conditioned cell culture medium, method to obtain the same and use of it for maintenance, proliferation and differentiation of mammalian cells
05/25/2010US7723092 Chondroitin polymerase and DNA encoding the same
05/25/2010US7723080 Murine α (1,3) fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such a plasmid
05/25/2010US7723074 Nucleic acid molecules encoding prostaglandin receptor proteins
05/25/2010US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1
05/25/2010US7723071 DNA molecules encoding opioid receptors and methods of use thereof
05/25/2010US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators
05/25/2010US7723047 enriching luminal restricted colony forming cells in a sample containing mammary gland cells ; use of the cell preparations in the study of cell biology and cancer
05/25/2010US7723017 Adding a metabolic supplement (such as pyruvate, inosine, adenine), and optionally dibasic sodium phosphate and/or monobasic sodium phosphate at least once to red blood cells; and storing under conditions of oxygen-free
05/25/2010US7722896 Biocompatible polyarylates of diphenol compounds and poly(alkylene oxide) dicarboxylic acids, articles formed therefrom and therapeutic uses are disclosed.
05/25/2010US7722883 Genetic vaccine against PWD circovirus
05/25/2010US7722875 Antibodies that bind canine pancreatic lipase
05/25/2010US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells
05/25/2010US7722872 Treatment of cancer with antibodies to costimulating polypeptide of T cells
05/25/2010US7722867 Nucleotide sequences coding chimeric immunoglobulin specific for epidermal growth factor receptor; treatment and prevention of cell proliferative disorders
05/25/2010US7722863 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
05/25/2010US7722862 Regulatory T cells suppress autoimmunity
05/25/2010US7722616 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy
05/25/2010US7721898 Coating material for leukocyte removal filter and the filter
05/25/2010CA2646779A1 Bioscience ix
05/25/2010CA2469393C Processes for the measurement of the potency of glatiramer acetate
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2366187C A new class of enzymes in the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
05/25/2010CA2321964C Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
05/25/2010CA2241786C Novel amp activated protein kinase
05/25/2010CA2223837C Aav transduction of myoblasts
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/25/2010CA2195446C Growth control for cells encapsulated within bioartificial organs
05/20/2010WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
05/20/2010WO2010057110A1 Methods and compositions for long term hematopoietic repopulation
05/20/2010WO2010057108A1 Imprinting in very small embryonic-like (vsel) stem cells
05/20/2010WO2010057045A2 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
05/20/2010WO2010057039A2 Encapsulation of pancreatic cells derived from human pluripotent stem cells
05/20/2010WO2010057015A1 Kidney structures and methods of forming the same
05/20/2010WO2010056831A2 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
05/20/2010WO2010056808A2 Compositions and methods for re-programming and re-differentiating cells
05/20/2010WO2010056755A2 Microfluidic embryo and gamete culture systems
05/20/2010WO2010056336A1 Cells for joint fluid
05/20/2010WO2010056328A1 Isolated renal cells and uses thereof
05/20/2010WO2010056144A2 Foxp3+ natural kiler t-cells and the treatment of immune related diseases
05/20/2010WO2010056099A1 Cell regeneration compound
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055666A1 Nitrile hydratase variant
05/20/2010WO2010055616A1 Additive for differentiation induction culture medium, and use thereof
05/20/2010WO2010055208A1 Modified avidins binding to small ligands
05/20/2010WO2010035136A3 Expansion of embryonic stem cells
05/20/2010WO2010035119A3 Vaccine adjuvants
05/20/2010WO2010033230A3 Use of fluorescent protien in cyanobacteria and algae for improving photosynthesis and preventing cell damage
05/20/2010WO2010032008A3 Dendritic cell modulatory molecule
05/20/2010WO2009152084A3 Adipose tissue-derived stem cells for veterinary use
05/20/2010WO2009138855A3 Methods and systems for the production of granulosa cells
05/20/2010US20100125917 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
05/20/2010US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof
05/20/2010US20100125130 Tumour necrosis factor binding ligands
05/20/2010US20100125099 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
05/20/2010US20100125080 Compounds for inflammation and immune-related uses
05/20/2010US20100124783 Methods and Compositions for Cell Attachment and Cultivation on Planar Substrates
05/20/2010US20100124782 Composition For Repairing Defect In Skin Or Gingival Soft Tissue And Method Of Culturing Autologous Fibroblasts
05/20/2010US20100124781 Pluripotent Stem Cell Culture on Micro-Carriers
05/20/2010US20100124775 Process for treating cultured cells
05/20/2010US20100124574 Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs
05/20/2010US20100124569 Amnion derived adherent cells
05/20/2010US20100124564 Encapsulation of pancreatic cells derived from human pluripotent stem cells
05/20/2010US20100124556 Novel shigella protein antigens and methods
05/20/2010US20100124555 Compositions and Methods for Treating Pancreatic Tumors
05/20/2010US20100124553 Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
05/20/2010US20100124551 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
05/20/2010US20100124547 Compositions and methods for inhibiting expression of factor vii genes
05/20/2010CA2743668A1 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
05/20/2010CA2743666A1 Optically-based stimulation of target cells and modifications thereto
05/20/2010CA2743502A1 Foxp3+ natural killer t-cells and the treatment of immune related diseases
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743459A1 Isolated renal cells and uses thereof
05/20/2010CA2743305A1 Anti-cxcr1 compositions and methods
05/20/2010CA2742107A1 Method of producing serum-free insulin-free factor vii
05/20/2010CA2707026A1 Anti-human il-21 monoclonal antibodies
05/19/2010EP2186905A1 Method of producing heterogeneous protein
05/19/2010EP2186901A2 Mutations in the BCR-Abl-tyrosine kinase associated with resistance to STI-571
05/19/2010EP2186900A2 Variants of ADP-Glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186893A1 Production and use of epitope-tagged hepatitis c virus particle
05/19/2010EP2186892A1 Anti-cd20 monoclonal antibodies
05/19/2010EP2186889A1 Cdca1 peptide and pharmaceutical agent comprising the same
05/19/2010EP2186888A1 Transgenic non-human animals capable of producing heterologous antibodies
05/19/2010EP2186885A1 Animal-free cell culture method
05/19/2010EP2186884A2 HCV-anti-core monoclonal antibody
05/19/2010EP2186883A1 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
05/19/2010EP2186882A1 Dry powder cells and cell culture reagents and methods of production thereof
05/19/2010EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/19/2010EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 1827